Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Malaria

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 78 articles:
HTML format
Text format



Single Articles


    May 2019
  1. HSIANG MS, Ntshalintshali N, Kang Dufour MS, Dlamini N, et al
    Active case-finding for malaria: A three-year national evaluation of optimal approaches to detect infections and hotspots through reactive case detection in the low transmission setting of Eswatini.
    Clin Infect Dis. 2019 May 16. pii: 5490610. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. DATTA D, Conroy AL, Castelluccio PF, Ssenkusu JM, et al
    Elevated cerebrospinal fluid tau protein concentrations on admission are associated with long-term neurologic and cognitive impairment in Ugandan children with cerebral malaria.
    Clin Infect Dis. 2019 May 2. pii: 5482454. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2019
  3. COOPER DJ, Rajahram GS, William T, Jelip J, et al
    Plasmodium knowlesi malaria in Sabah, Malaysia, 2015-2017: ongoing increase in incidence despite near-elimination of the human-only Plasmodium species.
    Clin Infect Dis. 2019 Mar 19. pii: 5393645. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. KARUNAJEEWA H, Berman J
    Is the epidemiology of Plasmodium knowlesi changing and what does this mean for malaria control in South East Asia?
    Clin Infect Dis. 2019 Mar 19. pii: 5386571. doi: 10.1093.
    PubMed     Text format    


  5. ELKET N, Kendjo E, Thellier M, Assoumou L, et al
    Propensity score analysis of artesunate versus quinine for severe imported Plasmodium falciparum malaria in France.
    Clin Infect Dis. 2019 Mar 15. pii: 5381062. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2019
  6. YEO TW, Weinberg JB, Lampah DA, Kenangalem E, et al
    Glycocalyx Breakdown is Associated with Severe Disease and Fatal Outcome in Plasmodium falciparum Malaria.
    Clin Infect Dis. 2019 Feb 12. pii: 5316441. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2019
  7. GEORGIADOU A, Cunnington AJ
    Shedding of the Vascular Endothelial Glycocalyx - a Common Pathway to Severe Malaria?
    Clin Infect Dis. 2019 Jan 29. pii: 5304008. doi: 10.1093.
    PubMed     Text format    


  8. MORDMULLER B, Sulyok M, Egger-Adam D, Resende M, et al
    First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria.
    Clin Infect Dis. 2019 Jan 10. pii: 5281109. doi: 10.1093/cid/ciy1140.
    PubMed     Text format     Abstract available


  9. RAJAHRAM GS, Cooper DJ, William T, Grigg MJ, et al
    Deaths from Plasmodium knowlesi malaria: case series and systematic review.
    Clin Infect Dis. 2019 Jan 8. pii: 5280309. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2018
  10. DEJON-AGOBE JC, Ateba-Ngoa U, Lalremruata A, Homoet A, et al
    Controlled human malaria infection of healthy lifelong malaria-exposed adults to assess safety, immunogenicity and efficacy of the asexual blood stage malaria vaccine candidate GMZ2.
    Clin Infect Dis. 2018 Dec 18. pii: 5252072. doi: 10.1093/cid/ciy1087.
    PubMed     Text format     Abstract available


  11. ACCROMBESSI M, Yovo E, Fievet N, Cottrell G, et al
    Effects of Malaria in the First Trimester of Pregnancy on Poor Maternal and Birth Outcomes in Benin.
    Clin Infect Dis. 2018 Dec 18. pii: 5251978. doi: 10.1093/cid/ciy1073.
    PubMed     Text format     Abstract available


  12. SCHLAGENHAUF P, Patel D
    <<Who>> <<Where>> and <<Why>> moves to checkmate imported malaria?
    Clin Infect Dis. 2018 Dec 7. pii: 5233130. doi: 10.1093/cid/ciy1044.
    PubMed     Text format    


  13. MOYO QM, Besser M, Lynn R, Lever AML, et al
    Persistence of imported Malaria into the UK: an epidemiological review of risk factors and at risk groups.
    Clin Infect Dis. 2018 Dec 7. pii: 5233009. doi: 10.1093/cid/ciy1037.
    PubMed     Text format     Abstract available


    November 2018
  14. GIRMA S, Cheaveau J, Mohon AN, Marasinghe D, et al
    Prevalence and epidemiological characteristics of asymptomatic malaria based on ultrasensitive diagnostics: A cross-sectional study.
    Clin Infect Dis. 2018 Nov 26. pii: 5208346. doi: 10.1093/cid/ciy1005.
    PubMed     Text format     Abstract available


    October 2018
  15. DOBANO C, Nhabomba AJ, Manaca MN, Berthoud T, et al
    A balanced pro-inflammatory and regulatory cytokine signature in young African children is associated with lower risk of clinical malaria.
    Clin Infect Dis. 2018 Oct 31. pii: 5151218. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. MWESIGWA J, Achan J, Affara M, Wathuo M, et al
    Mass drug administration with dihydroartemisinin-piperaquine and malaria transmission dynamics in The Gambia - a prospective cohort study.
    Clin Infect Dis. 2018 Oct 10. pii: 5125954. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. GULER JL, Rosenthal PJ
    Mass drug administration to control and eliminate malaria in Africa: how do we best utilize the tools at hand?
    Clin Infect Dis. 2018 Oct 10. pii: 5125955. doi: 10.1093.
    PubMed     Text format    


  18. LAU CL, Ramsey L, Mills L, Furuya-Kanamori L, et al
    Drug-free holidays: Compliance, tolerability, and acceptability of a 3-day atovaquone/proguanil schedule for pre-travel malaria chemoprophylaxis in Australian travellers.
    Clin Infect Dis. 2018 Oct 3. pii: 5114398. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2018
  19. MURIUKI JM, Mentzer AJ, Kimita W, Ndungu FM, et al
    Iron Status and Associated Malaria Risk Among African Children.
    Clin Infect Dis. 2018 Sep 14. pii: 5096852. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. PETO TJ, Tripura R, Maude RJ
    Strengthen village malaria reporting to better target reservoirs of persistent infections in Southeast Asia.
    Clin Infect Dis. 2018 Sep 14. pii: 5096854. doi: 10.1093.
    PubMed     Text format    


    August 2018
  21. KURTIS JD, Raj DK, Michelow IC, Park S, et al
    Maternally derived antibodies to Schizont Egress Antigen-1 and protection of infants from severe malaria.
    Clin Infect Dis. 2018 Aug 25. pii: 5079188. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. CHU CS, Phyo AP, Turner C, Win HH, et al
    Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
    Clin Infect Dis. 2018 Aug 24. pii: 5079011. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018

  23. Community-based malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment with Sulfadoxine-pyrimethamine: A Multicentre (The Gambia, Burkina Faso and Benin) Cluster Randomised Controlled Trial.
    Clin Infect Dis. 2018 Jun 29. pii: 5046692. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. STEINER-MONARD V, Kamaka K, Karoui O, Roethlisberger S, et al
    The Candidate Blood Stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase I Trial in Exposed and Non Exposed Volunteers.
    Clin Infect Dis. 2018 Jun 26. pii: 5045203. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. CHU CS, Phyo AP, Lwin KM, Win HH, et al
    Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.
    Clin Infect Dis. 2018 Jun 8. pii: 5034800. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. ARINAITWE E, Dorsey G, Nankabirwa JI, Kigozi SP, et al
    Association between Recent Overnight Travel and Risk of Malaria: A Prospective Cohort Study at Three Sites in Uganda.
    Clin Infect Dis. 2018 Jun 4. pii: 5032708. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  27. KHO S, Andries B, Poespoprodjo JR, Commons RJ, et al
    High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia.
    Clin Infect Dis. 2018 May 16. pii: 4996544. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. AGUAS R, Maude RJ, Gomes MGM, White LJ, et al
    Infectivity of Chronic Malaria Infections and Its Consequences for Control and Elimination.
    Clin Infect Dis. 2018 May 10. pii: 4994834. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. TUIKUE NDAM N, Tornyigah B, Dossou AY, Escriou G, et al
    Persistent Plasmodium falciparum infection in women with an intent to become pregnant is a risk factor for pregnancy-associated malaria.
    Clin Infect Dis. 2018 May 4. pii: 4992589. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  30. IPPOLITO MM, Denny JE, Langelier C, Sears CL, et al
    Malaria and the microbiome: a systematic review.
    Clin Infect Dis. 2018 Apr 26. pii: 4986462. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. DENG C, Huang B, Wang Q, Wu W, et al
    Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa.
    Clin Infect Dis. 2018 Apr 24. pii: 4984633. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  32. SUTANTO I, Kosasih A, Elyazar IRF, Simanjuntak DR, et al
    Negligible Impact of Mass Screening and Treatment on Meso-endemic Malaria Transmission at West Timor in Eastern Indonesia: A Cluster-Randomised Trial.
    Clin Infect Dis. 2018 Mar 22. pii: 4951459. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. KEENE CM, Dondorp A, Crawley J, Ohuma EO, et al
    A Competing-Risk Approach to Modelling Length of Stay in Severe Malaria Patients in South-East Asia and the Implications for Planning of Hospital Services.
    Clin Infect Dis. 2018 Mar 19. pii: 4942414. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. SAVIC RM, Jagannathan P, Kajubi R, Huang L, et al
    Intermittent Preventive Treatment for Malaria in Pregnancy: Optimization of Target Concentrations of Dihydroartemisinin-Piperaquine.
    Clin Infect Dis. 2018 Mar 14. pii: 4933916. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. PLEWES K, Kingston HWF, Ghose A, Wattanakul T, et al
    Acetaminophen as a Renoprotective Adjunctive Treatment in Patients with Severe and Moderately Severe Falciparum Malaria: A Randomized, Controlled, Open-Label Trial.
    Clin Infect Dis. 2018 Mar 12. pii: 4930781. doi: 10.1093.
    PubMed     Text format     Abstract available


  36. TRIPURA R, Peto TJ, Nguon C, Davoeung C, et al
    A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multi Drug Resistant Falciparum Malaria in Cambodian Villages.
    Clin Infect Dis. 2018 Mar 7. pii: 4924016. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. OLDENBURG CE, Guerin PJ, Berthe F, Grais RF, et al
    Malaria and nutritional status among children with severe acute malnutrition in Niger: a prospective cohort study.
    Clin Infect Dis. 2018 Mar 7. pii: 4924398. doi: 10.1093.
    PubMed     Text format     Abstract available


  38. GRIGG MJ, William T, Barber BE, Rajahram GS, et al
    Age-Related Clinical Spectrum of Plasmodium knowlesi Malaria and Predictors of Severity.
    Clin Infect Dis. 2018 Mar 5. pii: 4828216. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  39. HOGAN B, Eibach D, Krumkamp R, Sarpong N, et al
    Malaria Coinfections in Febrile Pediatric Inpatients: A Hospital-Based Study From Ghana.
    Clin Infect Dis. 2018 Feb 2. pii: 4835722. doi: 10.1093/cid/cix1120.
    PubMed     Text format     Abstract available


  40. VALMASEDA A, Macete E, Nhabomba A, Guinovart C, et al
    Identifying Immune Correlates of Protection Against Plasmodium falciparum Through a Novel Approach to Account for Heterogeneity in Malaria Exposure.
    Clin Infect Dis. 2018;66:586-593.
    PubMed     Text format     Abstract available


    January 2018
  41. SUGIARTO SR, Moore BR, Makani J, Davis TME, et al
    Artemisinin Therapy for Malaria in Hemoglobinopathies: A Systematic Review.
    Clin Infect Dis. 2018 Jan 23. pii: 4822535. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  42. MOMBO-NGOMA G, Remppis J, Sievers M, Zoleko Manego R, et al
    Efficacy and safety of fosmidomycin-piperaquine as non-artemisinin-based combination therapy for uncomplicated falciparum malaria - A single-arm, age-de-escalation proof of concept study in Gabon.
    Clin Infect Dis. 2017 Dec 26. pii: 4774674. doi: 10.1093/cid/cix1122.
    PubMed     Text format     Abstract available


  43. EYAL M, Rahav G, Eli S
    Vivax malaria chemoprophylaxis: the role of Atovaquone-proguanil, compared to other options.
    Clin Infect Dis. 2017 Dec 7. pii: 4706214. doi: 10.1093/cid/cix1077.
    PubMed     Text format     Abstract available


    October 2017
  44. BOUAZIZ O, Courtin D, Cottrell G, Milet J, et al
    Is placental malaria a long term risk factor for mild malaria attack in infancy? Revisiting a paradigm.
    Clin Infect Dis. 2017 Oct 21. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2017
  45. GRIGG MJ, William T, Barber BE, Rajahram GS, et al
    Artemether-lumefantrine versus chloroquine for the treatment of uncomplicated Plasmodium knowlesi malaria (CAN KNOW): an open-label randomized controlled trial.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. ROSSI G, Van den Bergh R, Nguon C, Debackere M, et al
    Adapting reactive case detection strategies for falciparum malaria in a low-transmission area in Cambodia.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2017
  47. TOURE OA, Mwapasa V, Sagara I, Gaye O, et al
    Assessment of Efficacy and Safety of Arterolane Maleate-Piperaquine Phosphate Dispersible Tablets in Comparison With Artemether-Lumefantrine Dispersible Tablets in Pediatric Patients With Acute Uncomplicated Plasmodium falciparum Malaria: A Phase 3, R
    Clin Infect Dis. 2017 Aug 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. BOYCE R, Reyes R, Matte M, Ntaro M, et al
    Use of a Dual-Antigen Rapid Diagnostic Test to Screen Children for Severe Plasmodium falciparum Malaria in a High-Transmission, Resource-Limited Setting.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  49. BROOKS HM, Jean Paul MK, Claude KM, Houston S, et al
    Malaria in an Internally Displaced Persons Camp in the Democratic Republic of the Congo.
    Clin Infect Dis. 2017;65:529-530.
    PubMed     Text format    


    July 2017
  50. ROSSI G, De Smet M, Khim N, Kindermans JM, et al
    Performances of Rapid Diagnostic Testing in Patients with Suspected Malaria in Cambodia, a Low-Endemicity Country Aiming for Malaria Elimination.
    Clin Infect Dis. 2017 Jul 26. doi: 10.1093.
    PubMed     Text format    


  51. FRIED M, Kurtis JD, Swihart B, Pond-Tor S, et al
    Systemic Inflammatory Response to Malaria During Pregnancy Is Associated With Pregnancy Loss and Preterm Delivery.
    Clin Infect Dis. 2017 Jul 20. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2017
  52. TINE RC, Sylla K, Faye BT, Poirot E, et al
    Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial.
    Clin Infect Dis. 2017 Jun 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  53. GRUELL H, Hamacher L, Jennissen V, Tuchscherer A, et al
    On taking a different route: an unlikely case of malaria by nosocomial transmission.
    Clin Infect Dis. 2017 Jun 2. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  54. WYSS K, Wangdahl A, Vesterlund M, Hammar U, et al
    Obesity and Diabetes as Risk Factors for Severe Plasmodium falciparum Malaria: Results from a Swedish Nationwide Study.
    Clin Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  55. MONCUNILL G, Mpina M, Nhabomba AJ, Aguilar R, et al
    Distinct TH1 and TH2 cellular responses associated with malaria protection and risk in RTS,S/AS01E vaccinees.
    Clin Infect Dis. 2017 May 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  56. BJORKMAN A, Cook J, Sturrock H, Msellem M, et al
    Spatial Distribution of Falciparum Malaria Infections in Zanzibar: Implications for Focal Drug Administration Strategies Targeting Asymptomatic Parasite Carriers.
    Clin Infect Dis. 2017;64:1236-1243.
    PubMed     Text format     Abstract available


    April 2017
  57. DAVIS NL, Wiener J, Juliano JJ, Adair L, et al
    Co-trimoxazole prophylaxis, asymptomatic malaria parasitemia, and infectious morbidity in HIV-exposed uninfected infants in Malawi: The BAN study.
    Clin Infect Dis. 2017 Apr 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  58. CHICO RM, Chaponda EB, Ariti C, Chandramohan D, et al
    Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections.
    Clin Infect Dis. 2017;64:1043-1051.
    PubMed     Text format     Abstract available


  59. IPPOLITO MM, Johnson J, Mullin C, Mallow C, et al
    The Relative Effects of Artemether-lumefantrine and Non-artemisinin Antimalarials on Gametocyte Carriage and Transmission of Plasmodium falciparum: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2017 Apr 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  60. OLUPOT-OLUPOT P, Engoru C, Uyoga S, Muhindo R, et al
    High Frequency of Blackwater Fever Among Children Presenting to Hospital With Severe Febrile Illnesses in Eastern Uganda.
    Clin Infect Dis. 2017;64:939-946.
    PubMed     Text format     Abstract available


    March 2017
  61. NEUMAYR A, Paris D, Genton B, Hatz C, et al
    Artemether-lumefantrine treatment failure in nonimmune European travelers with P. falciparum malaria: 5.3% now and 5.3% then - need to reconsider dosing in patients from non-endemic regions?
    Clin Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format    


  62. RANADIVE N, Kunene S, Darteh S, Ntshalintshali N, et al
    Limitations of Rapid Diagnostic Testing in Patients with Suspected Malaria: A Diagnostic Accuracy Evaluation from Swaziland, a Low-Endemicity Country Aiming for Malaria Elimination.
    Clin Infect Dis. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  63. RAOUF S, Mpimbaza A, Kigozi R, Sserwanga A, et al
    Resurgence of malaria following discontinuation of indoor residual spraying of insecticide in a previously high transmission intensity area of Uganda.
    Clin Infect Dis. 2017 Mar 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  64. PORTUGAL S, Tran TM, Ongoiba A, Bathily A, et al
    Treatment of Chronic Asymptomatic Plasmodium falciparum Infection Does Not Increase the Risk of Clinical Malaria Upon Reinfection.
    Clin Infect Dis. 2017;64:645-653.
    PubMed     Text format     Abstract available


    February 2017
  65. DRANCOURT M, Raoult D
    Malaria Therapy for Ebola Virus Infection.
    Clin Infect Dis. 2017 Feb 10. doi: 10.1093.
    PubMed     Text format    


  66. WHITE NJ
    The Consequences of Treating Asymptomatic Malaria Parasitemia.
    Clin Infect Dis. 2017 Feb 8. doi: 10.1093.
    PubMed     Text format    


  67. SMIT MA, Michelow IC, Glavis-Bloom J, Wolfman V, et al
    Characteristics and Outcomes of Pediatric Patients With Ebola Virus Disease Admitted to Treatment Units in Liberia and Sierra Leone: A Retrospective Cohort Study.
    Clin Infect Dis. 2017;64:243-249.
    PubMed     Text format     Abstract available


    January 2017
  68. SIQUEIRA AM, Alencar AC, Melo GC, Magalhaes BL, et al
    Fixed-Dose Artesunate-Amodiaquine Combination vs Chloroquine for Treatment of Uncomplicated Blood Stage P. vivax Infection in the Brazilian Amazon: An Open-Label Randomized, Controlled Trial.
    Clin Infect Dis. 2017;64:166-174.
    PubMed     Text format     Abstract available


    December 2016
  69. JEGEDE AS, Oshiname FO, Sanou AK, Nsungwa-Sabiiti J, et al
    Assessing Acceptability of a Diagnostic and Malaria Treatment Package Delivered by Community Health Workers in Malaria-Endemic Settings of Burkina Faso, Nigeria, and Uganda.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


  70. CASTELLANI J, Mihaylova B, Ajayi IO, Siribie M, et al
    Quantifying and Valuing Community Health Worker Time in Improving Access to Malaria Diagnosis and Treatment.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


  71. FALADE CO, Ajayi IO, Nsungwa-Sabiiti J, Siribie M, et al
    Malaria Rapid Diagnostic Tests and Malaria Microscopy for Guiding Malaria Treatment of Uncomplicated Fevers in Nigeria and Prereferral Cases in 3 African Countries.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


  72. SINGLOVIC J, Ajayi IO, Nsungwa-Sabiiti J, Siribie M, et al
    Compliance With Malaria Rapid Diagnostic Testing by Community Health Workers in 3 Malaria-Endemic Countries of Sub-Saharan Africa: An Observational Study.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


  73. SIRIBIE M, Ajayi IO, Nsungwa-Sabiiti J, Afonne C, et al
    Training Community Health Workers to Manage Uncomplicated and Severe Malaria: Experience From 3 Rural Malaria-Endemic Areas in Sub-Saharan Africa.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


  74. CASTELLANI J, Nsungwa-Sabiiti J, Mihaylova B, Ajayi IO, et al
    Impact of Improving Community-Based Access to Malaria Diagnosis and Treatment on Household Costs.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


  75. AJAYI IO, Nsungwa-Sabiiti J, Siribie M, Falade CO, et al
    Feasibility of Malaria Diagnosis and Management in Burkina Faso, Nigeria, and Uganda: A Community-Based Observational Study.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


    October 2016
  76. SONDEN K, Wyss K, Jovel I, Vieira da Silva A, et al
    High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case Series.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  77. PARIKH S, Kajubi R, Huang L, Ssebuliba J, et al
    Antiretroviral choice for HIV impacts antimalarial exposure and treatment outcomes in Ugandan children.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    April 2014
  78. KAKURU A, Jane A, Muhindo M, Ikilezi G, et al
    Artemisinin-based Combination Therapies are Efficacious and Safe for Treatment of Uncomplicated Malaria in HIV-infected Ugandan Children.
    Clin Infect Dis. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malaria is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: